Assignee
ERYTECH PHARMA
FR·13 granted patents·11 pending applications·62 citations·filing 2013–2024
Top patents by PatentIndex Score
24 records- 0194US9950049B2Composition and therapeutic anti-tumour vaccineERYTECH PHARMA·Filed 2016·Granted Apr 24, 2018·26 cites·22 claims
- 0290US10780151B2Composition and therapeutic anti-tumour vaccineERYTECH PHARMA·Filed 2018·Granted Sep 22, 2020·4 cites·18 claims
- 0390US10046009B2Method of treatment using a pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactorERYTECH PHARMA·Filed 2015·Granted Aug 14, 2018·14 cites·15 claims
- 0480US10273444B2Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytesERYTECH PHARMA·Filed 2013·Granted Apr 30, 2019·4 cites·19 claims
- 0579US11141468B2Method of treating a mammal, including human, against cancer using methionine and asparagine depletionERYTECH PHARMA·Filed 2017·Granted Oct 12, 2021·3 cites·9 claims
- 0679US2024366694A1Phage therapy of e coli infectionsERYTECH PHARMA·Filed 2024·Application pending·0 cites
- 0778US10780126B2Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursorERYTECH PHARMA·Filed 2018·Granted Sep 22, 2020·2 cites·14 claims
- 0878US9580739B2Test for predicting neutralization of asparaginase activityERYTECH PHARMA·Filed 2014·Granted Feb 28, 2017·3 cites·27 claims
- 0977US9968663B2Erythrocytes containing arginine deiminaseERYTECH PHARMA·Filed 2015·Granted May 15, 2018·3 cites·7 claims
- 1073US12280080B2Antibacterial composition and uses thereofERYTECH PHARMA·Filed 2023·Granted Apr 22, 2025·0 cites·11 claims
- 1173US10286008B2Method for stabilising suspensions of red blood cells encapsulating an active ingredientERYTECH PHARMA·Filed 2014·Granted May 14, 2019·3 cites·16 claims
- 1267US11957724B2Phage therapy of E coli infectionsERYTECH PHARMA·Filed 2020·Granted Apr 16, 2024·0 cites·13 claims
- 1367US11458170B2Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursorERYTECH PHARMA·Filed 2020·Granted Oct 4, 2022·0 cites·19 claims
- 1466US2021077602A1Composition and therapeutic anti-tumour vaccineERYTECH PHARMA·Filed 2020·Application pending·0 cites
- 1560US2021268082A1METHOD OF INDUCING IMMUNE TOLERANCE BY ADMINISTERING ACTIVE PRINCIPLE-LOADING RBC'sERYTECH PHARMA·Filed 2021·Application pending·0 cites
- 1656US2022040272A1Method of treating a mammal, including human, against cancer using methionine and asparagine depletionERYTECH PHARMA·Filed 2021·Application pending·0 cites
- 1755US2014363413A1Formulation and method for the prevention and treatment of bone metastases or other bone diseasesERYTECH PHARMA·Filed 2014·Application pending·0 cites
- 1853US2014010795A1Formulation and method for the prevention and treatment of bone metastases or other bone diseasesERYTECH PHARMA·Filed 2013·Application pending·0 cites
- 1950US2022193208A1Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiencyERYTECH PHARMA·Filed 2022·Application pending·0 cites
- 2050US2015086521A1Medicament for the Treatment of Acute Myeloid Leukemia (AML)ERYTECH PHARMA·Filed 2013·Application pending·0 cites
- 2149US2021403571A1Synergistic combinations of methionine depletion agents and immune checkpoint modulatorsERYTECH PHARMA·Filed 2019·Application pending·0 cites
- 2247US2016120956A1Composition of erythrocytes encapsulating phenylalanine hydroxylase and therapeutic use thereofERYTECH PHARMA·Filed 2014·Application pending·0 cites
- 2344US2023226218A1Red Cell Extracellular Vesicles (RCEVs) Containing Cargoes and Methods of Use and Production ThereofERYTECH PHARMA·Filed 2021·Application pending·0 cites
- 2443US11273210B2Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiencyERYTECH PHARMA·Filed 2018·Granted Mar 15, 2022·0 cites·19 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →